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An outbreak of postsurgical infections caused by rapidly growing mycobacteria has been ongoing in Brazil
since 2004. The degrees of similarity of the rpoB and hsp65 sequences from the clinical isolates and the
corresponding sequences from both the Mycobacterium massiliense and the M. bolletii type strains were above
the accepted limit for interspecies variability, leading to conflicting identification results. Therefore, an
extensive characterization of members of theM. chelonae-M. abscessus group was carried out. TheM. abscessus,
M. chelonae, M. immunogenum, M. massiliense, and M. bolletii type strains and a subset of clinical isolates were
analyzed by biochemical tests, high-performance liquid chromatography, drug susceptibility testing, PCR-
restriction enzyme analysis of hsp65 (PRA-hsp65), rpoB, and hsp65 gene sequencing and analysis of phyloge-
netic trees, DNA-DNA hybridization (DDH), and restriction fragment length polymorphism (RFLP) analysis
of the 16S rRNA gene (RFLP-16S rRNA). The clinical isolates and the M. abscessus, M. massiliense, and M.
bolletii type strains could not be separated by phenotypic tests and were grouped in the phylogenetic trees
obtained. The results of DDH also confirmed the >70% relatedness of the clinical isolates and theM. abscessus,
M. massiliense, and M. bolletii type strains; and indistinguishable RFLP-16S rRNA patterns were obtained. On
the contrary, the separation of clinical isolates and the M. abscessus, M. massiliense, and M. bolletii type strains
fromM. chelonae andM. immunogenum was supported by the results of PRA-hsp65, DDH, and RFLP-16S rRNA
and by the rpoB and hsp65 phylogenetic trees. Taken together, these results led to the proposition that M.
abscessus,M. massiliense, andM. bolletii represent a single species, that ofM. abscessus. Two subspecies are also
proposed, M. abscessus subsp. abscessus and M. abscessus subsp. massiliense, and these two subspecies can be
distinguished by two different PRA-hsp65 patterns, which differ by a single HaeIII band, and by differences in
their rpoB (3.4%) and hsp65 (1.3%) sequences.
Since 2004, a series of localized skin and soft tissue infec-
tions caused by rapidly growing mycobacteria have occurred in
Brazil in patients who have undergone invasive procedures,
such as laparoscopic, arthroscopic, plastic surgery, or cosmetic
interventions (12, 16, 23, 37). In 4 years, more than 2,000 cases
were officially reported to Brazilian federal authorities, who
consider this problem an epidemiological emergency (5). Al-
most all isolates studied so far have belonged to the Mycobac-
terium chelonae-M. abscessus group (39). The majority of them
were identified as members of two recently described emerging
pathogens, Mycobacterium massiliense (3) and Mycobacterium
bolletii (1), both of which belong to the Mycobacterium chelo-
nae-M. abscessus group.
All five members of the Mycobacterium chelonae-M. absces-
sus group, M. chelonae, M. abscessus (21), Mycobacterium im-
munogenum (40), M. massiliense (3), and M. bolletii (1), are
nearly indistinguishable phenotypically. Common features in-
clude growth in less than 7 days, the absence of pigmentation,
better growth at 30°C than at 35°C, a positive 3-day arylsulfa-
tase test result, a negative nitrate reductase test result, and a
negative iron uptake test result (41). Two biochemical tests,
sodium chloride tolerance and the utilization of citrate, are
useful in distinguishing the five members (1, 3, 40, 41).
Antimicrobial susceptibility can also be used to differentiate
the members of the M. chelonae-M. abscessus group. M. ab-
scessus is generally susceptible to cefoxitin (MIC  16 g/ml)
and M. chelonae is resistant (MIC 128 g/ml). Otherwise, M.
abscessus is resistant to tobramycin (MIC  16 g/ml) and M.
chelonae is susceptible (MIC 4 g/ml) (9). M. immunogenum
is resistant to both drugs (40). M. massiliense was initially
reported to be susceptible to doxycycline (3), but clinical iso-
lates with intermediate susceptibility and also resistance to this
drug have also been described (30, 37). M. bolletii was de-
scribed to be a highly resistant species, and clarithromycin was
among the drugs to which it was resistant (1). However, the
results displayed by these tests can vary between strains, as has
been shown for M. massiliense (3, 30). Lipid analysis by high-
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performance liquid chromatography (HPLC) produces very
similar mycolic acid patterns for M. chelonae, M. abscessus, and
M. immunogenum and thus has limited discriminatory power
(10). The HPLC profiles of M. massiliense and M. bolletii have
not yet been reported.
Genotypic characterization of the group has shown that the
16S rRNA sequences of M. chelonae and M. abscessus differ by
only 4 bp, while they have identical hypervariable region A
sequences (9). Both M. massiliense and M. bolletii show 100%
16S rRNA sequence similarity to the 16S rRNA sequence of
M. abscessus (1, 3). Finally, the M. immunogenum 16S rRNA
sequence differs from the corresponding sequences of M. ab-
scessus and M. chelonae by 8 bp and 10 bp, respectively.
PCR-restriction enzyme analysis (PRA) of a 441-bp frag-
ment of the 65-kDa heat shock protein-encoding gene, hsp65
(PRA-hsp65), has thus far yielded five different patterns within
the members of the M. chelonae-M. abscessus group: M. che-
lonae has a single pattern (pattern 1), while M. abscessus and
M. immunogenum have two patterns each (patterns 1 and 2)
(13, 29, 40). M. massiliense and M. bolletii have identical PRA-
hsp65 patterns, and these in turn, are identical to pattern 2 of
M. abscessus (1, 3). The M. abscessus PRA-hsp65 pattern 2 was
also found in 152 isolates from the Brazilian outbreak men-
tioned above (data not shown).
The sequence of the rpoB gene has been demonstrated to be
a powerful tool for the delineation of bacterial species (4) and
was applied to the identification of rapidly growing mycobac-
teria, including members of the M. chelonae-M. abscessus
group (2). The degree of interspecies variation found in the
rpoB sequence is variable. Nevertheless, a 3% cutoff value can
generally be applied to the mycobacteria, but some exceptions
to that rule have been described. Analysis of interspecies vari-
ations in the rpoB gene sequence showed that the members of
the Mycobacterium avium complex have a range of 4.5 to 5.7%
sequence divergence (7) compared to the rpoB sequence of the
closely related species M. marinum and M. ulcerans, whose
rpoB sequences showed 0.4% divergence from each other (4).
On the other hand, M. mucogenicum and M. abscessus have
shown wider internal heterogeneity in the rpoB gene sequence,
with the latter having up to 4.3% internal species variation (2).
The papers describing M. massiliense and M. bolletii have
indicated that a specific sequence of the rpoB gene is a main
characteristic in these species (1, 3). Consequently, sequence
analysis of the rpoB gene as well as of the hsp65 gene, which we
used in a previous study, led to the identification of several
isolates from surgical patients as M. massiliense and other
isolates from mesotherapy patients as M. bolletii because of the
highest degrees of similarity of their rpoB and hsp65 gene
sequences (37). Several unclear findings, however, emerged
from that analysis. High degrees of similarity of the rpoB se-
quences of surgical isolates to the rpoB sequences of both M.
massiliense (99.72%) and M. bolletii (98.45%) were detected.
Moreover, the rpoB sequences of isolates from patients under-
going mesotherapy showed 100% similarity to the rpoB se-
quence of M. bolletii and 98.54% similarity to that of M. mas-
siliense. According to the 3% cutoff that has been proposed (2),
all isolates could therefore be identified either as M. massil-
iense or as M. bolletii on the basis of their rpoB gene sequences.
Similar results were observed with the hsp65 sequences. The
hsp65 sequences of surgical isolates showed 100% and 99.25%
similarities to the hsp65 sequences of M. massiliense and M.
bolletii, respectively. Again, the hsp65 sequences of isolates
from patients who had undergone mesotherapy displayed
100% similarity to the hsp65 sequence of M. bolletii and
99.24% similarity to the hsp65 sequence of M. massiliense. For
hsp65, the value of 97% similarity is suggested by McNabb et
al. (25) as the limit for the separation of species.
These inconclusive results prompted us to undertake an
extensive phenotypic and genotypic characterization of the iso-
lates from the Brazilian outbreaks. We applied a wide set of
procedures, including DNA-DNA hybridization (DDH), which
is so far considered the “gold standard” for the delineation of
bacterial species (4, 31). Selected isolates from the outbreaks
were compared to each other and also to reference strains
representative of the five members of the M. chelonae-M. ab-
scessus group. We showed that the DNA-DNA relatedness
clearly identifies M. massiliense and M. bolletii, together with
our clinical isolates, as M. abscessus, indicating that all of these
isolates make up a single genomic species. Finally, taking into
account the internal variability detected in the sequence of M.
abscessus, we propose the description of two subspecies within
this species.
MATERIALS AND METHODS
Mycobacterial strains. Six clinical isolates and five reference strains were
included in this study. Three isolates from the state of Para in Brazil were
previously identified as M. massiliense (two were from the laparoscopic surgery
outbreak [referred to as isolates B5 and B31 in this report] and one was from an
abscess that formed after an intramuscular injection [referred to as isolate B67
in this report]), and three isolates from the state of Para were previously iden-
tified as M. bolletii and were from patients who had undergone mesotherapy (37).
The latter three isolates are referred to as B60, B61, and B66 in this report. The
type strains of the five species M. abscessus, M. chelonae, M. immunogenum, M.
massiliense, and M. bolletii were included as reference strains. The M. fortuitum
type strain (ATCC 6841) was also used as an outgroup and a control in some
experiments. Bacteria were cultivated in Mueller-Hinton liquid or solid medium;
Middlebrook 7H9 broth supplemented with albumin, dextrose, and catalase; or
Middlebrook 7H10 solid medium supplemented with oleic acid, albumin, dex-
trose, and catalase. Frozen stocks were prepared.
Phenotypic identification. (i) Biochemical tests. The isolates were evaluated
for a panel of biochemical and cultural features by standard procedures (18). The
tests included analysis of the growth rate; growth at 25°C and 45°C; pigment
production; colony morphology; growth on MacConkey agar; biochemical tests
(nitrate reduction; Tween hydrolysis; tellurite reduction; and niacin, catalase,
beta-glucosidase, arylsulfatase, and urease tests); and tolerance to thiophene-
carboxylic acid, tiacetazone, p-nitrobenzoic acid, isoniazid, hydroxylamine,
oleate, NaCl, and sodium citrate.
(ii) HPLC. HPLC of cell wall mycolic acids, which may be a valid aid in the
identification of mycobacterial species, was carried out as reported before (12).
(iii) Susceptibility testing. MICs were determined by the microdilution
method, according to the recommendations of the CLSI (formerly NCCLS) (27),
with commercially available microplates (Sensititer RGMYCO; Trek Diagnostic
Systems Inc., Cleveland, OH).
Genotypic identification. (i) DNA isolation. Total genomic DNA was purified
from liquid bacterial cultures as described previously (36).
(ii) PRA-hsp65. The band patterns produced by PRA-hsp65 were obtained as
described by Telenti et al. (33) and were compared to those in the PRASITE
database (http://app.chuv.ch/prasite/index.html).
(iii) DNA sequencing and phylogenetic analysis. The hsp65 and rpoB gene
sequences were obtained and analyzed as described by Viana-Niero et al. (37).
The corresponding sequences from the type strains included in this study were
also retrieved from the GenBank database for comparative purposes. The align-
ment of the rpoB and hsp65 gene sequences was performed with ClustalX
(version 2.0) software (22). Two separate phylogenetic trees were constructed for
both genes by using M. tuberculosis strain H37Rv (ATCC 27294) as the outgroup.
The evolutionary history was generated by the neighbor-joining method. The
evolutionary distances were computed by use of the Kimura two-parameter
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model and bootstrap analysis with 1,000 replications. Phylogenetic analysis was
performed with MEGA (version 4) software (32).
DNA-DNA similarity. The total genomic relationships of DNAs were investi-
gated for the six clinical isolates and the corresponding type strains of M.
abscessus, M. chelonae, M. immunogenum, M. massiliense, and M. bolletii. M.
fortuitumT DNA was also analyzed so that DNA from a non-closely related
fast-growing mycobacterium was included. DDH experiments were performed
on membrane filters by a dot blot-based procedure, as described previously (17).
Genomic DNAs from M. massiliense CIP 108297T and M. bolletii CIP 108541T
were radioactively labeled in vitro and were used as probes to hybridize with 500
ng of each unlabeled DNA. Unlabeled DNAs were dot blotted and bound to
nylon membranes (Hybond-N; Amersham). The relative binding ratios (ex-
pressed as percentages) were calculated from the counts of bound homologous
DNA, as measured with a Typhon Trio apparatus (GE Healthcare). The amount
of DNA fixed in each dot was calculated by measuring the amount of radioac-
tivity when the 16S rRNA gene was used as a second probe (17).
RFLP of 16S rRNA gene. RFLP analysis of the 16S rRNA gene was also
performed. This procedure allowed the identification of the number of rrn
operons per genome carried by the mycobacteria (15). A previously described
experimental procedure (14) was used, with the exception that ECL buffer
(Amersham) was used for both the prehybridization and the hybridization steps.
RESULTS
Phenotypic identification. The biochemical and culture tests
turned out to be poorly discriminative (Table 1). Most of the
clinical isolates presented almost overlapping results with the
closely related rapid growers (M. abscessus, M. chelonae, M.
immunogenum). The few discrepancies within the strains be-
longing to the species M. massiliense and M. bolletii may well be
imputable to biological variability. The results of HPLC were
also poorly informative. All the species investigated here were,
in fact, characterized by a single pattern, with only minor
differences being detected among the species (Fig. 1).
Although the majority of the test results confirmed the sus-
ceptibility patterns available in the literature for the reference
strains (3, 9, 30, 40), several clear differences emerged (Table
2). The reference strain of M. massiliense, as well as two of
three M. massiliense clinical strains (strains B67 and B31),
turned out to be susceptible to amikacin (MIC range, 8 to 16
g/ml for all except for one strain, strain B5; Table 1) while in
the species nova description, a MIC of 48 g/ml has been
reported (3). In contrast, there was a discrepancy in the MICs
of the tetracyclines, with all of our strains, including the M.
massiliense reference strain, which has been reported to have a
MIC of 4 g/ml (3), being resistant (MIC  32 g/ml). The
results obtained with the commercial microplate, which in-
cluded minocycline, were, in fact, confirmed by the doxycycline
test, which was performed by the same technique with the
prepared antibiotic. Even more striking were the discrepancies
concerning M. bolletii, whose species nova description (1) em-
phasized its resistance to clarithromycin (MIC  256 g/ml).
In contrast, all of our strains, including the M. bolletii reference
strain, were susceptible (MIC range, 0.12 to 1 g/ml).
Genotypic identification. Initially, the two methods that are
the more frequently applied to the identification of mycobac-
terial species were used, i.e., PRA-hsp65 gene and DNA se-
quencing of the two selected genome targets, namely, the rpoB
and hsp65 genes.
On the basis of the previously defined PRA-hsp65 patterns
(13, 37), the PRA-hsp65 type 2 pattern of M. abscessus was
shared by all six of our clinical isolates and by the M. massil-
iense and M. bolletii type strains (data not shown). The other
type strains showed the expected patterns, according to the
TABLE 1. Comparison of phenotypic and biochemical characteristics of isolates and strains
Phenotypic or
biochemical test
Result for the following isolates and strainsa:
1 2 3 4 5 6 7 8 9 10 11
Niacin accumulation           
Nitrate reduction           
68°C catalase       / /   
PNBb tolerance           
Catalase over 45 mm           
Pigmentation Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent Absent
Beta-glucosidase    /  /     
Tween 80 hydrolysis           
Growth rate Rapid Rapid Rapid Rapid Rapid Rapid Rapid Rapid Rapid Rapid Rapid
Growth at 25°C           
Growth at 45°C           
MacConkey growth           
Tellurite reduction           
3-day arylsulfatase           
Colony morphology SMc SM SM SM SM SM SM SM RGd SM SM
Urease           
TCHe tolerance           
Tiacetazone tolerance           
Hydroxylamine tolerance           
Isoniazid tolerance           
Oleic acid tolerance           
NaCl 5% tolerance           
Sodium citrate           
a Brazilian isolates, as follows: 1, B67; 2, B31; 3, B5; 4, B60; 5, B61; 6, B66. 7, M. bolletii CIP 108541; 8, M. massiliense CIP 108297; 9, M. abscessus ATCC 19977;
10, M. chelonae ATCC 35752; 11, M. immunogenum ATCC 700505.
b PNB, p-aminobenzoic acid.
c SM, smooth.
d RG, rough.
e TCH, thiophene-carboxylic acid.
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information in the PRASITE database (http://app.chuv.ch
/prasite/index.html).
rpoB and hsp65 sequencing. The sequences of region V of
the rpoB gene were compared. The rpoB gene sequences of the
Brazilian isolates were found to be almost identical to those of
the M. massilienseT and M. bolletiiT strains from GenBank
(greater than 98.5%) and were found to be closely related to
the rpoB sequence of M. abscessusT (96.5% and 95.6%, respec-
tively).
The rpoB sequences were translated into amino acid se-
quences for further comparison. Most of the nucleotide poly-
morphisms detected represented silent substitutions, with no
amino acid change in the corresponding protein sequences
being detected. The exceptions were the E/D, A/Q, A/E, and
T/L substitutions in the M. abscessusT rpoB sequence and the
V/I and N/D substitutions in the M. chelonaeT rpoB sequence
(data not shown). In both cases, substitutions appeared in a
nonconserved region from the RNA polymerase RPB10 inter-
action site, according to the Conserved Domain Database at
NCBI (24). Comparisons of the sequences from the hsp65 gene
indicated results similar to those corresponding to rpoB gene
sequences, with even higher percentages of similarities being
detected. The hsp65 sequence (401 bp) from the M. abscessus
type strain showed 98.5 and 98.7% similarities to the corre-
sponding sequences from M. massiliense and M. bolletii, respec-
tively. A higher similarity index (99.2%) between the corre-
sponding sequences from M. massiliense and M. bolletii was
observed. Again, the hsp65 gene sequences of the Brazilian
isolates were found to be almost identical to the M. massil-
ienseT and M. bolletiiT hsp65 sequences (greater than 99%) and
closely related to the M. abscessusT hsp65 sequence (98% sim-
ilarity). All nucleotide polymorphisms detected represented
silent substitutions.
The close relationship detected by comparison of the nucle-
otide sequences of both the rpoB and hsp65 genes is shown in
the phylogenetic trees (Fig. 2a and b, respectively).
DDH. Due to the high degree of similarity shown by our
selected isolates of M. massiliense, M. bolletii, and M. abscessus,
total DNA-DNA similarities were determined, because DDH
is considered the reference method for the delimitation of
bacterial species (4, 31). The results are summarized in Table
3. The levels of DDH obtained by using M. massilienseT and M.
bolletiiT as probes with DNA from M. abscessusT and all six
clinical isolates were greater than 70%, indicating that they all
belong to a single species. On the contrary, the level of hybrid-
ization with DNA from other species, including M. chelonaeT
FIG. 1. Comparison of representative HPLC mycolic acid patterns
of members of the M. chelonae-M. abscessus group. HMWIS, high-
molecular-weight internal standard.
TABLE 2. Antimicrobial susceptibility results for isolates and strains included in this study
Drug
MIC (g/ml) for the following isolates and strainsa:
1 2 3 4 5 6 7 8 9 10 11
Linezolid 32 32 32 8 32 16 8 8 16 2 32
Clarithromycin 1 0.5 0.25 0.12 0.5 0.12 0.12 0.25 0.25 0.25 0.25
Amikacin 16 16 32 16 16 8 8 8 16 8 16
Cefoxitin 64 256 64 128 32 64 64 64 32 256 256
Ceftriaxone 64 64 64 64 64 32 64 64 64 64 64
Imipenem 32 64 64 64 16 8 32 32 8 16 64
Tobramycin 32 64 64 16 16 64 16 16 16 2 16
Ciprofloxacin 16 16 16 16 16 16 8 16 8 0.5 8
Gatifloxacin 8 8 8 8 8 8 8 8 8 0.25 8
Minocycline 32 32 32 0.5 32 32 32 32 32 16 32
Amoxicillin-clavulanic acid 64/32 64/32 64/32 64/32 64/32 64/32 64/32 64/32 64 64 64
Trimethoprim-Sulfamethoxazole 8/152 8/152 8/152 8/152 8/152 8/152 8/152 8/152 152 76 152
a Strains 1 to 11 correspond to the strains described in footnote a of Table 1.
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and M. immunogenumT, was less than 44%, showing a clear
differentiation at the genomic level between these closely re-
lated species.
RFLP of 16S rRNA gene. RFLP analysis with 16S rRNA as
the probe was used to characterize the mycobacteria. Accord-
ing to the patterns obtained, all strains except M. fortuitum and
M. immunogenum have a single rrn operon per genome (Fig.
3). The patterns for M. fortuitum and M. immunogenum are in
agreement with the corresponding data published previously
(15, 40).
BamHI-digested DNAs showed a single band pattern for all
strains except M. fortuitum and M. immunogenum. Compared
to the bands from M. massiliense, M. bolletii, and M. abscessus,
the single band was slightly smaller for isolates B67, B31, B60,
and B66 and in these isolates was in a position similar to that
of the smaller single band shown by M. chelonae (Fig. 3a).
These close patterns were distinguished by using PstI as second
restriction enzyme.
The RFLP patterns of PstI-digested DNAs showed two
bands that were in identical positions for all six Brazilian iso-
lates, as well as M. massiliense, M. bolletii, and M. abscessus
(Fig. 3b). On the contrary, PstI-digested DNA from M. chelo-
FIG. 2. Phylogenetic tree based on rpoB (a) and hsp65 (b) gene sequences, showing the relationships between Brazilian clinical isolates (isolates
B5, B31, B60, B61, B66, and B67) and other type strains of selected rapidly growing mycobacteria. GenBank accession numbers are shown in
parentheses. M. tuberculosis ATCC 27294T was included as the outgroup.
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nae showed a different two-band pattern. These results showed
that the Brazilian isolates, together with M. massiliense and M.
bolletii, share RFLP-16S rRNA patterns with M. abscessus. It
has been shown that the RFLP-16S rRNA patterns are species
specific within rapidly growing mycobacteria (8, 14, 17, 26), and
therefore, they should all be considered the species M. absces-
sus, which is clearly differentiated from M. chelonae and M.
immunogenum according to their RFLP-16S rRNA patterns.
DISCUSSION
The increasing availability of gene sequences has had a tre-
mendous influence on the taxonomy of bacteria, particularly
that of the mycobacteria, with great increases in newly de-
scribed species occurring every year (34). Some of the newly
described species are considered emerging pathogens due to
their relationships to clinical outbreaks (20, 29, 37). Besides
the 16S rRNA gene, another conserved gene, rpoB, has widely
contributed to the characterization of the species in the genus
Mycobacterium (4). The degree of intraspecific rpoB sequence
similarity has been estimated to range from 98.2 to 100% (4),
with a few exceptions, such as the 4.3% intraspecies se-
quence divergence in the species M. abscessus (2).
Members of the M. chelonae-M. abscessus group are ubiqui-
tous environmental organisms frequently associated with
nosocomial outbreaks and pseudo-outbreaks (6, 20, 28, 29, 37,
38). Five related species with different associations with infec-
tion have been described within that group, making the proper
identification of members of this complex important for both
therapeutic management and epidemiological studies. The two
species most recently incorporated into the group are M. mas-
siliense and M. bolletii. Remarkably, the separation of these
species was established mainly on the basis of their different
rpoB gene sequences (1, 3). In the original description of these
species, important differences in antimicrobial susceptibilities
were also reported and were considered to support their sep-
aration.
In the recent outbreak of infections related to surgical and
cosmetic procedures occurring in Brazil, the isolates were ini-
tially identified as M. massiliense (isolates from surgical cases)
and M. bolletii (isolates from mesotherapy cases) (37). How-
ever, such identifications appeared to be inconclusive, with the
isolates showing several characteristics that would allow them
to be assigned to either one of the two species. In order to
clarify their identities, a subset of six clinical isolates was ex-
tensively analyzed and compared to type strains not only of M.
massiliense and M. bolletii but also of all other members of the
M. chelonae-M. abscessus group. The analysis undertaken in-
cluded both phenotypic and genotypic characterization.
M. massilienseT, M. bolletiiT, M. abscessusT, and the Brazilian
TABLE 3. DNA-DNA genomic pairing between M. massilienseT and M. bolletiiT and other species, including Brazilian clinical isolates
(B67, B31, B5, B60, B61, and B66)
Strain no. Assigned species Isolate or strain Procedure
% DNA-DNA relatedness obtained with
the probe fora:
M. massiliense M. bolletii
1 M. massiliense B67 Intramuscular injection 81.8  11.3 83.8 9.5
2 M. massiliense B31 Laparoscopic surgery 91.7  13.2 80.4 10.5
3 M. massiliense B5 Laparoscopic surgery 84.4  9.5 87.5 12.3
4 M. bolletii B60 Mesotherapy 91.7  8.2 104.3 8.2
5 M. bolletii B61 Mesotherapy 76.6  9.4 88.6 6.1
6 M. bolletii B66 Mesotherapy 90.5  12.4 105.7 14.3
7 M. bolletiiT CIP 108541 76.5 4.8 100
8 M. massilienseT CIP 108297 100 73.4  8.5
9 M. abscessusT ATCC 19977 92.02 13.4 95.5 12.9
10 M. chelonaeT ATCC 35752 28.1 1.2 44 1.1
11 M. immunogenumT ATCC 700505 20.3 1.1 22.4 9.04
12 M. fortuitumT ATCC 6841 5.7 2.3 4.3 1.9
a Data are mean values  standard deviation of two to five different experiments.
FIG. 3. RFLP-16S rRNA patterns of mycobacterial DNAs digested
with the restriction enzymes BamHI (a) and PstI (b). Lanes 1 to 11,
isolates 1 to 11, respectively, as described in footnote a of Table 1; lane
12, M. fortuitum ATCC 6841.
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clinical isolates could not be clearly distinguished on the basis
of their phenotypic characteristics. Biochemical tests produced
almost indistinguishable patterns (Table 1). HPLC analysis,
which is well known to be unable to differentiate M. abscessus,
M. chelonae, and M. immunogenum (10, 40), turned out to be
of no use with M. bolletii and M. massiliense (Fig. 1), whose
profiles had not been investigated before. Even more confusing
were the antimicrobial susceptibility data, especially with re-
gard to clarithromycin. In the species nova description by Ad-
ekambi et al. (1), who used a nonapproved CLSI method, a
MIC of 256 g/ml was reported for M. bolletii, while the
same type strain, as well as all other clinical isolates of the
same species, were fully susceptible on the basis of our find-
ings. In the only other study (19) in which the susceptibility of
M. bolletii has been investigated so far, again, resistance to
clarithromycin was detected, although the MIC range (8 to 16
g/ml) was very different from our MIC range and that of
Adekambi et al. (1).
M. abscessusT could be separated from M. massilienseT and
M. bolletiiT by use of the PRA-hsp65 pattern. The first species
showed the type 1 pattern of M. abscessus, while the latter two
shared the type 2 pattern of M. abscessus (1, 3, 37), with the
difference between the two patterns being limited to a single
HaeIII band. All the Brazilian clinical isolates under study also
had the type 2 pattern of M. abscessus.
Genetic sequencing of the rpoB region, as proposed by
Adekambi et al. (2) for the separation of rapidly growing
mycobacteria, confirmed the high degree of heterogeneity
within clinical isolates of M. abscessus, which was also reported
by the same authors. Our results showed that the similarities in
the rpoB gene sequences place M. abscessus, M. bolletii, and M.
massiliense with the Brazilian isolates on the same branch, in
which all their degrees of identity are within the range of M.
abscessus intraspecies variability (Fig. 2a). These results are
consistent with the similarities found in a different conserved
DNA target, the hsp65 gene (Fig. 2b), whose use has also been
proposed to be effective for the identification of mycobacteria
(25).
The global DNA-DNA pairing values still remain the gold
standard for the delineation of bacterial species (4, 9, 31, 42).
Therefore, with the aim of clarifying the differences found,
experiments were performed to analyze the total genomic re-
lationships of the DNAs from the Brazilian clinical isolates and
the type strains of the five species belonging to the M. chelo-
nae-M. abscessus group. In the experimental design, the DNAs
from M. massiliense and M. bolletii were used as probes. The
DDH results revealed the clear species separation of M. che-
lonae and M. immunogenum from M. massiliense and M.
bolletii, with the DDH values being less than 44% (Table 3).
On the contrary, M. massiliense and M. bolletii could not be
differentiated from each other or from M. abscessus, as the
total DDH values were greater than 70% (Table 3). High
hybridization values were also observed when the total DNAs
of M. massiliense and M. bolletii were compared to the DNAs
from the Brazilian clinical isolates (Table 3). According to
these results, the two recently described species as well as the
Brazilian clinical isolates appear to be members of the species
M. abscessus.
M. abscessus as well as M. chelonae, unlike the large majority
of rapidly growing mycobacteria, carry a single rrn operon per
genome (15). RFLP analysis of the 16S rRNA genes also
revealed in M. massiliense, M. bolletii, and the subset of Bra-
zilian clinical isolates (Fig. 3) the presence of a single rrn
operon per genome, similar to the findings for M. abscessus.
Moreover, their RFLP patterns, which have been character-
ized as being species specific within rapidly growing mycobac-
teria (8, 15, 17, 26), were identical to the RFLP pattern of M.
abscessus and different from the patterns of the other members
of the M. chelonae-M. abscessus group (Fig. 3).
All results presented above indicate that the Brazilian M.
abscessus, M. bolletii, and M. massiliense isolates belong to a
single species. Since their description, “M. massiliense” and
“M. bolletii” have been recognized to cause infectious diseases
worldwide (11, 19, 20, 30, 35, 37). According to our results,
from a public health perspective, the species responsible for all
those cases should actually be assigned to the species M. ab-
scessus.
The internal variability emerging from our findings and
other previous data (2, 6, 28, 38) for the species M. abscessus
suggests a new arrangement for the M. chelonae-M. abscessus
group, in which only three species, M. chelonae, M. immuno-
genum, and M. abscessus, would be present, with M. abscessus
being split into two subspecies, namely, M. abscessus subsp.
abscessus and M. abscessus subsp. massiliense. For the latter
subspecies, including the isolates previously identified as “M.
massiliense” and “M. bolletii,” the name “massiliense” was cho-
sen as it appeared first in the literature.
The two subspecies of M. abscessus can be distinguished
genotypically by their PRA pattern type (the M. abscessus type
1 pattern for M. abscessus subsp. abscessus and the M. abscessus
type 2 pattern for M. abscessus subsp. massiliense) and by
differences in the rpoB and hsp65 sequences. Thus, the 711-bp
rpoB sequence and the 401-bp hsp65 sequence from M. absces-
sus subsp. abscessus show similarities of less than 96.6% and
98.7%, respectively, with the sequences of M. abscessus subsp.
massiliense (which includes the species formerly named “M.
bolletii”).
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